Role of Remdesivir in COVID-19

Abstract

Remdesivir is an antiviral drug showed broad spectrum against viruses, also RNA polymerase inhibitor that’s why use to treat a variety of RNA virus infections. It is considered to be more effective against family of respiratory infection causing viruses including corona virus as compared to those whom it was originally synthesized like Hepatitis C and common cold viruses. On October 8, 2020, The National Institute of Allergy and Infectious Diseases has completed trials on COVID-19 patients and found Remdesivir satisfactory and beneficiary choice towards the recovery stairs of COVID-19. The pandemic of Covid-19 might wean down by season, but the possibility of reoccurrence exists. Thus, future clearance of Remdesivir might be critical for ensuring effective treatment, diminish mortality and permit early release.